About
Bicurion Therapeutics AB develops antibody-based therapeutics aimed at enhancing cancer immunotherapy.
Explore Bicurion Therapeutics AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Bicurion Therapeutics AB develops antibody-based therapeutics aimed at enhancing cancer immunotherapy.
Funding rounds, investor list, and risk signals — unlock with a subscription.